Shares of Carl Zeiss Meditec AG (ETR:AFX) have been assigned a consensus recommendation of “Hold” from the seven brokerages that are presently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and three have given a buy rating to the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is €45.75 ($53.82).

A number of equities research analysts recently issued reports on AFX shares. Berenberg Bank set a €48.00 ($56.47) target price on Carl Zeiss Meditec AG and gave the company a “buy” rating in a research report on Wednesday, September 20th. Deutsche Bank AG set a €40.00 ($47.06) target price on Carl Zeiss Meditec AG and gave the company a “neutral” rating in a research report on Tuesday, August 8th. DZ Bank AG reissued a “sell” rating on shares of Carl Zeiss Meditec AG in a research report on Thursday, October 19th. Commerzbank Ag set a €42.00 ($49.41) target price on Carl Zeiss Meditec AG and gave the company a “neutral” rating in a research report on Wednesday, August 2nd. Finally, Independent Research GmbH set a €44.00 ($51.76) target price on Carl Zeiss Meditec AG and gave the company a “neutral” rating in a research report on Tuesday, August 15th.

COPYRIGHT VIOLATION NOTICE: This piece of content was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another publication, it was illegally copied and reposted in violation of United States & international copyright & trademark law. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/10/29/carl-zeiss-meditec-ag-afx-receives-consensus-recommendation-of-hold-from-analysts.html.

Shares of Carl Zeiss Meditec AG (AFX) opened at 46.149 on Friday. The company has a 50 day moving average price of €44.05 and a 200 day moving average price of €44.14. Carl Zeiss Meditec AG has a 52 week low of €30.80 and a 52 week high of €47.80. The company has a market cap of €4.13 billion and a PE ratio of 31.182.

Carl Zeiss Meditec AG Company Profile

Carl Zeiss Meditec AG operates as a medical technology company worldwide. It operates through Ophthalmic Devices and Microsurgery segments. The Ophthalmic Devices segment offers optical biometers, ophthalmic microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.

Analyst Recommendations for Carl Zeiss Meditec AG (ETR:AFX)

Receive News & Stock Ratings for Carl Zeiss Meditec AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec AG and related stocks with our FREE daily email newsletter.